Table 2.
Total sample (n = 60) | Active (n = 40) | Placebo (n = 20) | p value | |||
---|---|---|---|---|---|---|
Demographic characteristics | ||||||
Age | 32.93 3 ± 7,58 | 32.85 3 ± 7,55 | 33.10 3 ± 7,85 | 0.91 | ||
Sexual activity | 46 (76.66%) | 31 (77.50%) | 15 (75.00%) | 1.00 | ||
Smoking | 18 (22.50%) | 13 (32.25%) | 5 (25.00%) | 0.77 | ||
Body mass index (kg/m2) | 23.73 ± 3.10 | 23.33 ± 3.46 | 22.53 ± 1.74 | 0.11 | ||
<18.5 | 1 (1.67%) | 1 (2.50%) | 0 (0.00%) | 1.00 | ||
18.5–24.9 | 38 (63.33%) | 23 (57.50%) | 15 (75.00%) | 0.25 | ||
25–29.9 | 19 (31.67%) | 14 (35.00%) | 5 (25.00%) | 0.56 | ||
≥30 | 2 (3.33%) | 2 (5.00%) | 0 (0.00%) | 1.00 | ||
Contraceptive use | 46 (76.66%) | 29 (72.50%) | 17 (85.00%) | 0,35 | ||
Oral | 13 (21.66%) | 11 (27.50%) | 2 (10.00%) | 0.19 | ||
Barrier | 19 (31.66%) | 11 (27.50%) | 8 (40.00%) | 0.38 | ||
Others | 14 (23.33%) | 7 (17.50%) | 7 (35.00%) | 0,20 |
Data are presented as means ± SD and percentages.